Grail

E474924

Grail is a biotechnology company focused on developing blood-based tests for early cancer detection using advanced genomic sequencing and data science.

All labels observed (1)

Label Occurrences
Grail canonical 2

How this entity was disambiguated

Statements (46)

Predicate Object
instanceOf biotechnology company ⓘ
cancer diagnostics company ⓘ
acquiredBy Illumina ⓘ
aimsTo enable multi-cancer screening from a single blood draw ⓘ
integrate cancer screening into routine care ⓘ
analyzes cell-free DNA ⓘ
methylation patterns ⓘ
collaboratesWith health systems ⓘ
research institutions ⓘ
countryOfHeadquarters United States ⓘ
dataApproach large-scale clinical data analysis ⓘ
population-scale studies ⓘ
detects cancer signals in blood ⓘ
multiple cancer types ⓘ
focusesOn blood-based cancer screening tests ⓘ
early cancer detection ⓘ
liquid biopsy ⓘ
foundedBy Illumina ⓘ
goal detect cancer at early stages ⓘ
reduce cancer mortality ⓘ
hasMajorInvestor Amazon-related investment entities ⓘ
Arch Venture Partners ⓘ
Bill Gates ⓘ
Jeff Bezos ⓘ
Johnson & Johnson Innovation ⓘ
linked to: Johnson & Johnson
headquartersLocation Menlo Park, California, United States ⓘ
industry biotechnology ⓘ
medical diagnostics ⓘ
market cancer screening ⓘ
oncology diagnostics ⓘ
product Galleri ⓘ
productType multi-cancer early detection test ⓘ
regulatoryEnvironment subject to FDA oversight ⓘ
researchArea cancer genomics ⓘ
circulating tumor DNA ⓘ
epigenetics ⓘ
oncology ⓘ
spinOffFrom Illumina ⓘ
testType blood test ⓘ
usesMethod pattern recognition in genomic data ⓘ
statistical modeling of cancer signals ⓘ
usesTechnology bioinformatics ⓘ
data science ⓘ
genomic sequencing ⓘ
machine learning ⓘ
next-generation sequencing ⓘ

How these facts were elicited

Referenced by (2)

Full triples — surface form annotated when it differs from this entity's canonical label.